Saved Results

No results saved yet.

Enter a patient name and hit Save on a result.

Clinical calculator summary

Palliative Prognostic Index

Five-factor additive score with two published, overlapping short-term survival thresholds.

Evidence-based context for fast calculator use

Purpose:
Support uncertainty-aware short-term prognostic assessment in advanced or terminal cancer.
Population:
Advanced or terminal cancer; originally developed and tested in a Japanese hospice inpatient cohort.
Factors:
PPS, Oral intake, Edema, Dyspnea at rest, Delirium
Reference:
Morita et al. Support Care Cancer. 1999;7(3):128-133. PMID: 10335930.
HomePalliative Prognostic Index (PPI)
Pin your most used calculators here by clicking the star in the dropdown.

Palliative Prognostic Index (PPI)

Clinical Context & Background

The Palliative Prognostic Index (PPI) is a five-factor additive score developed and tested in terminally ill patients with cancer in a Japanese hospice inpatient unit. It uses PPS, oral intake, edema, dyspnea at rest, and delirium; the total ranges from 0 to 15.
The original publication reported two independent, overlapping thresholds. PPI >4 predicts survival under 6 weeks (sensitivity 80%, specificity 77%), and PPI >6 predicts survival under 3 weeks (sensitivity 80%, specificity 85%). A score above 6 meets both thresholds. Scores at or below 4 do not establish survival beyond 6 weeks, and no result is a deterministic individual survival interval.
The original 1999 PPI predates PPSv2. If current PPSv2 is used operationally, apply its official definitions, leftward precedence, best-horizontal-fit method, and training guidance. References: Morita et al. Support Care Cancer. 1999; Stone et al. J Pain Symptom Manage. 2008; Downing. PPSv2 Q&A Manual. 2020.
Formula Logic
Add the five source-defined component points; exact total 0-15.

Reference Data

Published thresholdOriginal prediction targetOriginal performance
PPI > 4Survival <6 weeksSensitivity 80%; specificity 77%
PPI > 6Survival <3 weeksSensitivity 80%; specificity 85%

Clinical Workflow

Use, Interpret, And Continue The Patient Pathway

Expand for workflow guidance, limitations, examples, and related next steps.

When To Use

  • Use in advanced or terminal cancer when all five current bedside assessments are available.
  • If assigning PPS with current PPSv2, follow its official definitions, leftward precedence, and best-horizontal-fit instructions.

How To Interpret

  • PPI >4 meets the published threshold predicting survival under 6 weeks; PPI >6 meets both that threshold and the threshold predicting survival under 3 weeks.
  • Treat the original sensitivity and specificity values as cohort-level performance, not certainty for an individual.

What To Do Next

  • Document the components, total, thresholds met, assessment date, and reversible contributors.
  • Integrate the result with trajectory, clinical assessment, patient goals, and reassessment after material change.

Limitations

  • A score at or below 4 does not prove survival beyond 6 weeks, and the thresholds do not create mutually exclusive deterministic bands.
  • The original model predates PPSv2; present-day PPSv2 use requires accurate application of its later official definitions and should be documented as an operational adaptation.

Validated Population

Terminally ill patients with cancer in the original Japanese hospice inpatient cohorts; later prospective validation included hospital, hospice, and home-care settings.

Overlapping thresholds

A PPI of 6.5 meets both published thresholds while remaining a probabilistic cohort-level result.

Calculation verification history

Verified
  1. : Production browser revalidation

    • Three source-backed PPI cases passed through visible production controls at 0, exact 4.5, and 15 across both overlapping thresholds.
    • No unexpected N/A, literal undefined value, stale control, unsupported gauge, or browser-console error was observed.
    Download latest production check (Excel)

    Case-level evidence is retained in validation/browser-revalidation/palliative-prognostic-index-ppi-2026-08-03.json.

  2. : Production browser validation

    • Ten source-backed cases were exercised on the public production route through visible browser controls; 10/10 case records passed their expected-versus-observed assertions across 20 visible submissions.
    • Overall browser status: failed-console. medium: Production emitted minified React error #418 during route loads/reloads used by this run.
    • Case-level inputs, expected and observed results, reset/repeat behavior, failure reproductions, and console evidence are retained in the production-browser evidence record.

    Case-level production evidence is retained in validation/browser-production/palliative-prognostic-index-ppi.json.

  3. : Full validation test

    • Verified all 72 combinations and UI serializations, the 12/14/46 distribution, all 26 totals, scores 0/4/4.5/6/6.5/15, strict cutoffs, metrics, trace, malformed-input rejection, no-default/reset behavior, and immutability.
  4. : Correction history

    • Separated normal intake from reduced intake using the mouthfuls boundary, removed favorable defaults and coercive inputs, and replaced invented survival bands with the published overlapping PPI >4 and PPI >6 thresholds.

Verification confirms the calculator implementation against the cited model; it is not independent clinical validation, regulatory approval, or medical advice.

Found a possible issue? Report it to improve this calculator

Share This Calculator

Share:

Frequently Asked Questions

Does PPI <=4 mean survival will exceed 6 weeks?

No. Not meeting the PPI >4 positive threshold does not establish the opposite outcome for an individual.

What happens when PPI is above 6?

Both published thresholds are met: PPI >4 for survival under 6 weeks and PPI >6 for survival under 3 weeks.

Can current PPSv2 be used?

Only with its official definitions and rating method explicit. The original 1999 PPI predates PPSv2, so this is a later operational adaptation.

Evidence-based oncology decision support. Verify with clinical guidelines.